Company: ELV
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001156039-25-000046
Chunk: 62

Company: Elevance Health, Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 62
---
Us was computed based on the target level of performance being achieved. The table below sets forth the grant date fair value of the RSUs granted in 2024 and the PSUs granted in 2024 at the target level of performance and the maximum level of performance.

| Name            |     |   |           | Restricted  
 Stock Units 
 Granted     |     | Target | Performance Stock Units 
 Maximum                 |     |   |           |     |   |            |
|:----------------|:----|:--|----------:|:------------|:----|:-------|:------------------------|:----|:--|----------:|:----|:--|-----------:|
| Gail Boudreaux  |     | $ | 4,200,011 |             |     |        |                         |     | $ | 8,400,021 |     | $ | 16,800,043 |
| Mark Kaye       |     | $ | 1,375,048 |             |     |        |                         |     | $ | 2,750,096 |     | $ |  5,500,192 |
| Peter Haytaian  |     | $ | 1,200,360 |             |     |        |                         |     | $ | 2,399,721 |     | $ |  4,799,442 |
| Felicia Norwood |     | $ | 1,200,360 |             |     |        |                         |     | $ | 2,399,721 |     | $ |  4,799,442 |
| Morgan Kendrick |     | $ | 1,075,083 |             |     |        |                         |     | $ | 2,150,166 |     | $ |  4,300,332 |

(3) The amounts in the “Option Awards” column reflect the grant date fair value of stock option awards issued during the respective fiscal years pursuant to our Long-Term Incentive Plan in accordance with ASC 718.

The assumptions used in the calculation of the grant date fair value of the stock options are included in Note 15 to our audited consolidated financial statements included in Part II, Item 8 of our Form 10-K.

| 58 |

#### Executive Compensation
(4) The amounts in the “Non-Equity Incentive Plan Compensation” column represent cash AIP awards earned during the reported year but paid in the following year